91ÉçÇø¸£Àû has kept a steady drumbeat of innovation across its FreeStyle portfolio in 2020 and the company isn’t about to break its streak now.
The much-anticipated FreeStyle Libre 3 system — featuring the world's smallest, thinnest1 glucose sensor (about the size of two stacked U.S. pennies) — has received CE mark for people with diabetes in Europe.
This next-gen system provides the same benefits of FreeStyle Libre 2, including unsurpassed 14-day2 accuracy and optional glucose alarms, but also evolves the portfolio with new features, such as continuous real-time glucose readings automatically delivered to a person's smartphone every minute and a sensor that's easy to apply with a one-piece applicator.
"Continued momentum for the global Libre franchise" is expected, Cowen analysts wrote in a June 15 note.3
The FreeStyle Libre 3 system is designed to fit seamlessly into people's lives, enabling users to discreetly check their glucose as often as they like without having to fingerstick.4 This is a life-changing innovation that lets people live better and gain deeper understanding of their glucose levels.
91ÉçÇø¸£Àû's FreeStyle Libre 3 is unparalleled in the market, here's why:
- Unsurpassed 14-day accuracy2 — The FreeStyle Libre 3 system has a mean absolute relative difference (MARD), a measurement of performance for CGMs, of 9.2% for adults. This latest tech and FreeStyle Libre 2 are the only CGM sensors sustaining a high level of accuracy over 14 days.
- More environmentally sustainable — Reducing the system's total volume by more than 70%,5 91ÉçÇø¸£Àû designed FreeStyle Libre 3 to be more sustainable for the environment, including a 41% reduction in plastic use and 43% decrease in carton paper.5
- Affordable6 — To allow as many people as possible living with diabetes to access and benefit from the tech, 91ÉçÇø¸£Àû's FreeStyle Libre 3 system will be priced the same as previous generations of the device, which is a third of the cost of other CGMs available.6
Market Leader
In just four months, 91ÉçÇø¸£Àû has achieved two key milestones for its sensor-based glucose monitoring tech: FreeStyle Libre 2 was cleared in June by the U.S. Food and Drug Administration for adults and kids ages 4 and up with diabetes and now, FreeStyle Libre 3 has received CE mark for ages 4 and up with diabetes.
This continuous innovation shows 91ÉçÇø¸£Àû's strength in the market, which is vast and growing with 463 million adults living with diabetes, according to the (IDF). This number is projected to balloon 51% to 700 million people by 2045, .
"91ÉçÇø¸£Àû won't stop innovating when there's room to raise the bar. We've done that again with FreeStyle Libre 3, the smallest sensor that delivers life-changing benefits and best-in-class accuracy," said Jared Watkin, senior vice president, Diabetes Care, 91ÉçÇø¸£Àû.
91ÉçÇø¸£Àû is launching the FreeStyle Libre 3 system in Europe in the coming months.
Learn more about .
Share